Meeting
2020 Genitourinary Cancers Symposium
Patterns of use of chemotherapy with radiotherapy in the treatment of muscle-invasive bladder cancer: Data from the RAIDER randomized trial of adaptive radiotherapy.
Authors
Robert A. Huddart
The Royal Marsden NHS Foundation Trust, Surrey, United Kingdom
Robert A. Huddart , Rebecca Lewis , Clare Griffin , Roberto Alonzi , Alison Jane Birtle , Ananya Choudhury , Joanne Cresswell , Farshad Foroudi , Shaista Hafeez , Ann Henry , Ben Hindson , Duncan McLaren , Anita Mitra , Ashok Nikapota , Omi Parikh , Yvonne L. Rimmer , Isabel Syndikus , Mohini Anna Varughese , Emma Hall
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
26779187
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 503)
Abstract #
503
Poster Bd #
J4
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
A phase I/II feasibility study of cetuximab with 5FU and mitomycin C or cisplatin with concurrent radiotherapy in muscle invasive bladder cancer.
First Author: Nicholas D. James
Poster
2019 Genitourinary Cancers Symposium
Bladder-preserving therapy using a real-time tumor-tracking radiotherapy system for muscle-invasive bladder cancer.
First Author: Haruka Miyata
Poster
2016 ASCO Annual Meeting
Patterns of chemotherapy administration in bladder preservation therapy (BPT) for muscle-invasive bladder cancer (MIBC).
First Author: Tracy Lynn Rose
Poster
2014 Genitourinary Cancers Symposium
Radical cystectomy versus trimodality bladder-preserving therapy for muscle-invasive bladder cancer among elderly (80-84 years old) patients.
First Author: Shingo Hatakeyama